| scholarly article | Q13442814 |
| P50 | author | Daniel S Berman | Q89697826 |
| Gregg W Stone | Q90754539 | ||
| Roxy Senior | Q91296565 | ||
| Leslee J Shaw | Q94570815 | ||
| Rory Hachamovitch | Q114406980 | ||
| Marielle Scherrer-Crosbie | Q114406981 | ||
| Rob S B Beanlands | Q114406999 | ||
| Tali Sharir | Q114407006 | ||
| Gilbert Gosselin | Q114407007 | ||
| Paola E Smanio | Q114407008 | ||
| James K. Min | Q16213661 | ||
| Michael H. Picard | Q37386535 | ||
| Mouaz Al-Mallah | Q37828820 | ||
| Harmony R Reynolds | Q43271306 | ||
| P2093 | author name string | Lawrence M Phillips | |
| Matthias G Friedrich | |||
| Ami E Iskandrian | |||
| Raymond Y Kwong | |||
| Sean W Hayes | |||
| David J Maron | |||
| Marco Mazzanti | |||
| Abhi Goyal | |||
| P2860 | cites work | Automated quantification of myocardial perfusion SPECT using simplified normal limits | Q62492869 |
| Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction | Q74288420 | ||
| Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia | Q79757444 | ||
| 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study | Q80275837 | ||
| Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy | Q80681924 | ||
| Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) stud | Q84383774 | ||
| Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention | Q84761062 | ||
| Fractional flow reserve versus angiography for guiding percutaneous coronary intervention | Q28306779 | ||
| Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease | Q30305510 | ||
| Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascu | Q30411237 | ||
| A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 | ||
| Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 | ||
| Prognostic value of gated myocardial perfusion SPECT. | Q35723309 | ||
| Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction | Q37127474 | ||
| Gated SPECT perfusion imaging for the simultaneous assessment of myocardial perfusion and ventricular function in the BARI 2D trial: an initial report from the Nuclear Core Laboratory | Q40352362 | ||
| Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials | Q40414100 | ||
| Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography | Q40585925 | ||
| 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management | Q40975493 | ||
| Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease | Q43124900 | ||
| Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. | Q44771325 | ||
| Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial in | Q45007824 | ||
| Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia | Q45253615 | ||
| Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424. | Q45332629 | ||
| Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. | Q45962402 | ||
| Anatomy trumps all! | Q46010796 | ||
| Effect of PCI on quality of life in patients with stable coronary disease | Q46429326 | ||
| Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy. | Q46702432 | ||
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart | Q52956605 | ||
| Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Q61651378 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| lessons learned | Q1673259 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 969-975 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
| P1476 | title | Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. | |
| P478 | volume | 20 |
| Q48128845 | Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros |
| Q50455835 | Characteristics of images of angiographically proven normal coronary arteries acquired by adenosine-stress thallium-201 myocardial perfusion SPECT/CT-IQ[Symbol: see text]SPECT with CT attenuation correction changed stepwise |
| Q50041204 | Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization |
| Q85553612 | Evaluating left ventricular systolic dysfunction: Stress echocardiography |
| Q87304974 | Immortality time and serial myocardial perfusion imaging: Only those who do not die may repeat the exam |
| Q53048747 | Impact of SPECT myocardial perfusion imaging on cardiac care. |
| Q38676391 | Noninvasive Cardiac Imaging in Patients with Known and Suspected Coronary Artery Disease: What is in it for the Interventional Cardiologist? |
| Q40085577 | Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study. |
| Q37733364 | Revascularization and outcomes in Veterans with moderate to severe ischemia on myocardial perfusion imaging |
| Q97645740 | Revascularization versus drug therapy for coronary artery disease in patients aged over 80 years: a real-world study |
| Q88655901 | Serial cardiac SPECT studies: Technical issues and clinical implications |
| Q64092910 | Single-Photon Emission Computed Tomography Myocardial Ischemia Detection in High-Risk Asymptomatic Patients: Correlation with Coronary Calcium Score and High-Sensitivity C-Reactive Protein |
| Q48613788 | The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? |
| Q38747232 | The role of myocardial viability in contemporary cardiac practice |
| Q36383558 | The value of core lab stress echocardiography interpretations: observations from the ISCHEMIA Trial |
| Q53202166 | Transient Ischemic Dilatation during Stress Echocardiography: An Additional Marker of Significant Myocardial Ischemia. |
Search more.